Effectiveness of tyrosine kinase inhibitors on “uncommon” epidermal growth factor receptor mutations of unknown clinical significance in non–small cell lung cancer
Purpose: Clinical features of epidermal growth factor receptor (EGFR) mutations, L858R,
deletions in exon 19, T790M, and insertions in exon 20, in non–small cell lung cancer …
deletions in exon 19, T790M, and insertions in exon 20, in non–small cell lung cancer …
Effectiveness of tyrosine kinase inhibitors on" uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer
JY Wu, CJ Yu, YC Chang, CH Yang… - … : an official journal …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose Clinical features of epidermal growth factor receptor (EGFR) mutations, L858R,
deletions in exon 19, T790M, and insertions in exon 20, in non-small cell lung cancer …
deletions in exon 19, T790M, and insertions in exon 20, in non-small cell lung cancer …
[PDF][PDF] Effectiveness of Tyrosine Kinase Inhibitors on" Uncommon" Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non–Small Cell …
JY Wu, CJ Yu, YC Chang, CH Yang, JY Shih… - Clin Cancer …, 2011 - scholar.archive.org
Purpose: Clinical features of epidermal growth factor receptor (EGFR) mutations, L858R,
deletions in exon 19, T790M, and insertions in exon 20, in non–small cell lung cancer …
deletions in exon 19, T790M, and insertions in exon 20, in non–small cell lung cancer …
[引用][C] Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non―Small Cell …
JY WU, CJ YU, YC CHANG, CH YANG… - Clinical cancer …, 2011 - pascal-francis.inist.fr
Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor Receptor
Mutations of Unknown Clinical Significance in Non―Small Cell Lung Cancer CNRS Inist …
Mutations of Unknown Clinical Significance in Non―Small Cell Lung Cancer CNRS Inist …
Effectiveness of Tyrosine Kinase Inhibitors on “Uncommon” Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non–Small Cell Lung …
JY Wu, CJ Yu, YC Chang, CH Yang, JY Shih… - Clinical Cancer …, 2011 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: Clinical features of epidermal growth
factor receptor (EGFR) mutations, L858R, deletions in exon 19, T790M, and insertions in …
factor receptor (EGFR) mutations, L858R, deletions in exon 19, T790M, and insertions in …
[PDF][PDF] Effectiveness of Tyrosine Kinase Inhibitors on" Uncommon" Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non–Small Cell …
JY Wu, CJ Yu, YC Chang, CH Yang, JY Shih… - Clin Cancer …, 2011 - researchgate.net
Purpose: Clinical features of epidermal growth factor receptor (EGFR) mutations, L858R,
deletions in exon 19, T790M, and insertions in exon 20, in non–small cell lung cancer …
deletions in exon 19, T790M, and insertions in exon 20, in non–small cell lung cancer …
Effectiveness of tyrosine kinase inhibitors on" uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer.
JY Wu, CJ Yu, YC Chang, CH Yang… - … Cancer Research: an …, 2011 - europepmc.org
Purpose Clinical features of epidermal growth factor receptor (EGFR) mutations, L858R,
deletions in exon 19, T790M, and insertions in exon 20, in non-small cell lung cancer …
deletions in exon 19, T790M, and insertions in exon 20, in non-small cell lung cancer …